Assessment of [18F]fluoroethylflumazenil metabolites using high-performance liquid chromatography and tandem mass spectrometry

被引:9
作者
Levêque, P
de Hoffmann, E
Labar, D
Gallez, B
机构
[1] Catholic Univ Louvain, Unite Chim Pharmaceut & Radiopharm, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Lab Spectrometrie Masse, B-1348 Louvain, Belgium
[3] Catholic Univ Louvain, Unite Tomog Par Positrons, B-1348 Louvain, Belgium
[4] Catholic Univ Louvain, Lab Resonance Magnet Biomed, B-1200 Brussels, Belgium
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2001年 / 754卷 / 01期
关键词
F-18]fluoroethylflumazenil; metabolite; mass spectrometry;
D O I
10.1016/S0378-4347(00)00578-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple procedure using HPLC and tandem mass spectrometry has been developed for the determination of fluoroethylflumazenil metabolites. Samples were precipitated with acetonitrile, evaporated to dryness followed by reconstitution with methanol. As mobile phase, 50 mM ammonium formate-methanol (58:42, v/v) was used. The method is valid both for cold and radiolabelled metabolites. Various cold metabolites (hydroxylated and/or dealkylated) were identified in rat and human microsome preparations. Radiolabelled metabolites arise from two or more transformations including hydroxylation. The methodology developed can be applied for further characterisation of metabolites, and for the determination of non metabolised [F-18]fluoroethylflumazenil in routine clinical analysis. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 15 条
  • [1] CENTRAL BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN - ESTIMATION OF REGIONAL B(MAX) AND K(D) VALUES WITH POSITRON EMISSION TOMOGRAPHY
    ABADIE, P
    BARON, JC
    BISSERBE, JC
    BOULENGER, JP
    RIOUX, P
    TRAVERE, JM
    BARRE, L
    PETITTABOUE, MC
    ZARIFIAN, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (01) : 107 - 115
  • [2] ANALYTICAL STUDY OF MICROSOMES AND ISOLATED SUBCELLULAR MEMBRANES FROM RAT-LIVER .2. PREPARATION AND COMPOSITION OF MICROSOMAL FRACTION
    AMARCOSTESEC, A
    BEAUFAY, H
    WIBO, M
    THINESSE.D
    FEYTMANS, E
    ROBBI, M
    BERTHET, J
    [J]. JOURNAL OF CELL BIOLOGY, 1974, 61 (01) : 201 - 212
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] PLASMA PHARMACOKINETICS AND METABOLISM OF THE BENZODIAZEPINE ANTAGONIST [C-11] RO 15-1788 (FLUMAZENIL) IN BABOON AND HUMAN DURING POSITRON EMISSION TOMOGRAPHY STUDIES
    DEBRUYNE, D
    ABADIE, P
    BARRE, L
    ALBESSARD, F
    MOULIN, M
    ZARIFIAN, E
    BARON, JC
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1991, 16 (02) : 141 - 152
  • [5] Parametric images of benzodiazepine receptor concentration using a partial-saturation injection
    Delforge, J
    Spelle, L
    Bendriem, B
    Samson, Y
    Syrota, A
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (03) : 343 - 355
  • [6] PARAMETRIC INVIVO IMAGING OF BENZODIAZEPINE RECEPTOR DISTRIBUTION IN HUMAN BRAIN
    FREY, KA
    HOLTHOFF, VA
    KOEPPE, RA
    JEWETT, DM
    KILBOURN, MR
    KUHL, DE
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (05) : 663 - 672
  • [7] Hamkens W., 1999, Journal of Labelled Compounds and Radiopharmaceuticals, V42, pS510
  • [8] QUANTITATIVE INVIVO ANALYSIS OF BENZODIAZEPINE BINDING-SITES IN THE HUMAN BRAIN USING POSITRON EMISSION TOMOGRAPHY
    IYO, M
    ITOH, T
    YAMASAKI, T
    FUKUDA, H
    INOUE, O
    SHINOTOH, H
    SUZUKI, K
    FUKUI, S
    TATENO, Y
    [J]. NEUROPHARMACOLOGY, 1991, 30 (03) : 207 - 215
  • [9] KLOTZ U, 1988, EUR J ANAESTH, P103
  • [10] LOC'H C, 1991, Journal of Labelled Compounds and Radiopharmaceuticals, V30, P234